Literature DB >> 34214643

Western diet as a trigger of Alzheimer's disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration.

Angelika Więckowska-Gacek1, Anna Mietelska-Porowska1, Małgorzata Wydrych1, Urszula Wojda2.   

Abstract

An excess of saturated fatty acids and simple sugars in the diet is a known environmental risk factor of Alzheimer's disease (AD) but the holistic view of the interacting processes through which such diet may contribute to AD pathogenesis is missing. We addressed this need through extensive analysis of published studies investigating the effects of western diet (WD) on AD development in humans and laboratory animals. We reviewed WD-induced systemic alterations comprising metabolic changes, induction of obesity and adipose tissue inflammation, gut microbiota dysbiosis and acceleration of systemic low-grade inflammation. Next we provide an overview of the evidence demonstrating that WD-associated systemic alterations drive impairment of the blood-brain barrier (BBB) and development of neuroinflammation paralleled by accumulation of toxic amyloid. Later these changes are followed by dysfunction of synaptic transmission, neurodegeneration and finally memory and cognitive impairment. We conclude that WD can trigger AD by acceleration of inflammaging, and that BBB impairment induced by metabolic and systemic inflammation play the central role in this process. Moreover, the concurrence of neuroinflammation and Aβ dyshomeostasis, which by reciprocal interactions drive the vicious cycle of neurodegeneration, contradicts Aβ as the primary trigger of AD. Given that in 2019 the World Health Organization recommended focusing on modifiable risk factors in AD prevention, this overview of the sequential, complex pathomechanisms initiated by WD, which can lead from peripheral disturbances to neurodegeneration, can support future prevention strategies.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Blood-brain barrier impairment; Gut-brain axis; Metabolic syndrome; Neurodegeneration; Neuroinflammation; Obesity; Pathogenesis

Year:  2021        PMID: 34214643     DOI: 10.1016/j.arr.2021.101397

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  16 in total

1.  Association between ultra-processed food consumption and cognitive performance in US older adults: a cross-sectional analysis of the NHANES 2011-2014.

Authors:  Barbara R Cardoso; Priscila Machado; Euridice Martinez Steele
Journal:  Eur J Nutr       Date:  2022-07-01       Impact factor: 5.614

Review 2.  Nutrition, Physical Activity, and Other Lifestyle Factors in the Prevention of Cognitive Decline and Dementia.

Authors:  Ligia J Dominguez; Nicola Veronese; Laura Vernuccio; Giuseppina Catanese; Flora Inzerillo; Giuseppe Salemi; Mario Barbagallo
Journal:  Nutrients       Date:  2021-11-15       Impact factor: 5.717

Review 3.  Autophagy Balances Neuroinflammation in Alzheimer's Disease.

Authors:  Xuehua Cheng; Yong Wei; Zijun Qian; Li Han
Journal:  Cell Mol Neurobiol       Date:  2022-08-12       Impact factor: 4.231

Review 4.  Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics.

Authors:  Lucia Migliore; Fabio Coppedè
Journal:  Nat Rev Neurol       Date:  2022-09-30       Impact factor: 44.711

Review 5.  Overnutrition Induced Cognitive Impairment: Insulin Resistance, Gut-Brain Axis, and Neuroinflammation.

Authors:  Qin Zhang; Kangyu Jin; Bing Chen; Ripeng Liu; Shangping Cheng; Yuyan Zhang; Jing Lu
Journal:  Front Neurosci       Date:  2022-07-06       Impact factor: 5.152

6.  Saponins from Panax japonicus attenuate cognitive impairment in ageing rats through regulating microglial polarisation and autophagy.

Authors:  Xue-Jiao Pi; Qing-Qing Zhao; Jin-Xin Wang; Xu-Lan Zhang; Ding Yuan; Shan-Shan Hu; Yu-Min He; Chang-Cheng Zhang; Zhi-Yong Zhou; Ting Wang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

7.  Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer's Disease Mouse Model.

Authors:  Jiuyang Ding; Jian Huang; Dan Yin; Ting Liu; Zheng Ren; Shanshan Hu; Yuanliang Ye; Cuiyun Le; Na Zhao; Hongmei Zhou; Zhu Li; Xiaolan Qi; Jiang Huang
Journal:  Oxid Med Cell Longev       Date:  2021-11-05       Impact factor: 6.543

Review 8.  Natural Aporphine Alkaloids with Potential to Impact Metabolic Syndrome.

Authors:  Fei-Xuan Wang; Nan Zhu; Fan Zhou; Dong-Xiang Lin
Journal:  Molecules       Date:  2021-10-10       Impact factor: 4.411

9.  UCHL1 and Proteasome in Blood Serum in Relation to Dietary Habits, Concentration of Selected Antioxidant Minerals and Total Antioxidant Status among Patients with Alzheimer's Disease.

Authors:  Sylwia Bogdan; Anna Puścion-Jakubik; Katarzyna Klimiuk; Katarzyna Socha; Jan Kochanowicz; Ewa Gorodkiewicz
Journal:  J Clin Med       Date:  2022-01-14       Impact factor: 4.241

Review 10.  Effects of Intermittent Fasting on Brain Metabolism.

Authors:  Alex Brocchi; Eleni Rebelos; Angela Dardano; Michele Mantuano; Giuseppe Daniele
Journal:  Nutrients       Date:  2022-03-17       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.